Aarey Drugs

{
  "main_header": {
    "sid": 933527,
    "name": "Aarey Drugs",
    "stock_name": "Aarey Drugs",
    "full_name": "Aarey Drugs & Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/aarey-drugs",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "64.95",
    "chg": 0.94,
    "chgp": "1.47%",
    "dir": 1,
    "prev_price": "64.01",
    "mcapval": "181.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524412,
    "symbol": "AAREYDRUGS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 49,
    "indexname": "",
    "isin": "INE198H01019",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "72.28 k",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/aarey-drugs-933527-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Aarey Drugs & Pharmaceuticals Ltd Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3816566",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AareyDrugsPharm_stocks_hitting_lower_circuit_3816566.png",
        "date": "2026-02-02 12:00:19",
        "description": "Shares of Aarey Drugs & Pharmaceuticals Ltd plunged to their lower circuit limit on 2 Feb 2026, closing at ₹61.08, marking a maximum daily loss of 4.99%. The stock witnessed intense selling pressure, with volumes concentrated near the day’s low, signalling panic selling and a sharp decline in investor confidence amid deteriorating fundamentals and weak market sentiment."
      },
      {
        "title": "Aarey Drugs & Pharmaceuticals Ltd Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3814737",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AareyDrugsPharm_stocks_hitting_lower_circuit_3814737.png",
        "date": "2026-02-01 14:00:11",
        "description": "Shares of Aarey Drugs & Pharmaceuticals Ltd plunged to their lower circuit limit on 1 Feb 2026, succumbing to intense selling pressure that saw the stock lose nearly 5% in a single session. The micro-cap pharmaceutical company’s stock performance has deteriorated sharply, reflecting mounting investor concerns and a sustained downtrend that has wiped out over 8% in the past two days."
      },
      {
        "title": "Aarey Drugs & Pharmaceuticals Ltd Hits Upper Circuit Amid Strong Buying Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-ltd-hits-upper-circuit-amid-strong-buying-pressure-3807920",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AareyDrugsPharm_stocks_hitting_upper_circuit_3807920.png",
        "date": "2026-01-28 15:00:10",
        "description": "Aarey Drugs & Pharmaceuticals Ltd witnessed a robust surge in its share price on 28 Jan 2026, hitting the upper circuit limit of 4.99% to close at ₹71.30. This significant price movement was driven by intense buying interest, resulting in a trading halt due to regulatory freeze mechanisms. The stock outperformed its sector and broader market indices, reflecting renewed investor enthusiasm despite its current Strong Sell rating."
      },
      {
        "title": "Aarey Drugs & Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aarey-drugs-pharmaceuticals-ltd-is-rated-strong-sell-3803957",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AareyDrugsPharm_mojoScore_3803957.png",
        "date": "2026-01-25 10:10:42",
        "description": "Aarey Drugs & Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 Nov 2025. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the company’s current position as of 25 January 2026, providing investors with the latest insights into the stock’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Why is Aarey Drugs & Pharmaceuticals Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-aarey-drugs-pharmaceuticals-ltd-fallingrising-3802752",
        "imagepath": "",
        "date": "2026-01-24 00:58:10",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Strong Relative Performance Against Benchmarks</strong></p>\n<p>The stock’s upward movement on 23-Jan is part of a broader trend of outperformance. Over the past week, Aarey Drugs &amp; Pharmaceuticals Ltd has gained 7.05%, significantly surpassing the Sensex’s decline of 2.43% during the same period. This divergence highlights the stock’s resilience amid a generally bearish market environment. Year-to-date, the stock has appreciated by 1.68%, while the Sensex has fallen by 4.32%, further emphasising its relative strength.</p>\n<p>Looking at longer-term returns, the stock has delivered impressive gains of 36.28% over the last year, compared to the Sensex’s 6.56%. Over three and five years, the stock’s cumulative returns stand at 84.75% and 152.09% respectively, more than doubling the benchmark..."
      },
      {
        "title": "Aarey Drugs & Pharmaceuticals Ltd Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3791059",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AareyDrugsPharm_stocks_hitting_lower_circuit_3791059.png",
        "date": "2026-01-12 13:00:19",
        "description": "Shares of Aarey Drugs & Pharmaceuticals Ltd plunged to their lower circuit limit on 12 Jan 2026, reflecting intense selling pressure and panic among investors. The stock closed at ₹66.67, down 3.89% on the day, marking a significant underperformance relative to its sector and the broader market."
      },
      {
        "title": "Aarey Drugs & Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aarey-drugs-pharmaceuticals-ltd-is-rated-strong-sell-3778734",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AareyDrugsPharm_mojoScore_3778734.png",
        "date": "2026-01-02 10:10:32",
        "description": "Aarey Drugs & Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 28 Nov 2025, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 02 January 2026, providing investors with the latest perspective on the company’s position."
      },
      {
        "title": "Aarey Drugs & Pharmaceuticals Ltd Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3773547",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AareyDrugsPharm_stocks_hitting_lower_circuit_3773547.png",
        "date": "2025-12-29 14:00:11",
        "description": "Shares of Aarey Drugs & Pharmaceuticals Ltd plunged to their lower circuit limit on 29 Dec 2025, succumbing to intense selling pressure that saw the stock lose nearly 5% in a single session. The micro-cap pharmaceutical company’s stock closed at ₹67.65, down ₹3.12 or 4.41%, marking a continuation of a sharp downward trend amid weak investor sentiment and unfilled supply on the order books."
      },
      {
        "title": "Aarey Drugs Sees Revision in Market Evaluation Amid Challenging Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aarey-drugs-downgraded-to-strong-sell-amid-weak-fundamentals-and-risky-valuation-3765524",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AareyDrugs_mojoScore_3765524.png",
        "date": "2025-12-22 10:10:35",
        "description": "Aarey Drugs, a microcap player in the Pharmaceuticals & Biotechnology sector, has undergone a revision in its market evaluation reflecting recent shifts in its financial and technical outlook. This adjustment follows a detailed reassessment of the company’s quality, valuation, financial trends, and technical indicators, highlighting ongoing challenges and market dynamics affecting its performance."
      }
    ],
    "total": 553,
    "sid": "933527",
    "stock_news_url": "https://www.marketsmojo.com/news/aarey-drugs-pharmaceuticals-933527"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Aarey Drugs & Pharmaceuticals Ltd has declared <strong>1%</strong> dividend, ex-date: 13 Dec 18",
          "dt": "2018-12-13",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Aarey Drugs & Pharmaceuticals Ltd has announced <strong>1:5</strong> bonus issue, ex-date: 25 Jun 12",
          "dt": "2012-06-25",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Aarey Drugs & Pharmaceuticals Ltd has announced <strong>2:1</strong> rights issue, ex-date: 19 Jan 12",
          "dt": "2012-01-19",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Aarey Drugs & Pharmaceuticals Ltd Hits Lower Circuit Amid Heavy Selling Pressure

2026-02-02 12:00:19

Shares of Aarey Drugs & Pharmaceuticals Ltd plunged to their lower circuit limit on 2 Feb 2026, closing at ₹61.08, marking a maximum daily loss of 4.99%. The stock witnessed intense selling pressure, with volumes concentrated near the day’s low, signalling panic selling and a sharp decline in investor confidence amid deteriorating fundamentals and weak market sentiment.

Read full news article

Aarey Drugs & Pharmaceuticals Ltd Hits Lower Circuit Amid Heavy Selling Pressure

2026-02-01 14:00:11

Shares of Aarey Drugs & Pharmaceuticals Ltd plunged to their lower circuit limit on 1 Feb 2026, succumbing to intense selling pressure that saw the stock lose nearly 5% in a single session. The micro-cap pharmaceutical company’s stock performance has deteriorated sharply, reflecting mounting investor concerns and a sustained downtrend that has wiped out over 8% in the past two days.

Read full news article

Aarey Drugs & Pharmaceuticals Ltd Hits Upper Circuit Amid Strong Buying Pressure

2026-01-28 15:00:10

Aarey Drugs & Pharmaceuticals Ltd witnessed a robust surge in its share price on 28 Jan 2026, hitting the upper circuit limit of 4.99% to close at ₹71.30. This significant price movement was driven by intense buying interest, resulting in a trading halt due to regulatory freeze mechanisms. The stock outperformed its sector and broader market indices, reflecting renewed investor enthusiasm despite its current Strong Sell rating.

Read full news article

Aarey Drugs & Pharmaceuticals Ltd is Rated Strong Sell

2026-01-25 10:10:42

Aarey Drugs & Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 Nov 2025. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the company’s current position as of 25 January 2026, providing investors with the latest insights into the stock’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Why is Aarey Drugs & Pharmaceuticals Ltd falling/rising?

2026-01-24 00:58:10

Strong Relative Performance Against Benchmarks

The stock’s upward movement on 23-Jan is part of a broader trend of outperformance. Over the past week, Aarey Drugs & Pharmaceuticals Ltd has gained 7.05%, significantly surpassing the Sensex’s decline of 2.43% during the same period. This divergence highlights the stock’s resilience amid a generally bearish market environment. Year-to-date, the stock has appreciated by 1.68%, while the Sensex has fallen by 4.32%, further emphasising its relative strength.

Looking at longer-term returns, the stock has delivered impressive gains of 36.28% over the last year, compared to the Sensex’s 6.56%. Over three and five years, the stock’s cumulative returns stand at 84.75% and 152.09% respectively, more than doubling the benchmark...

Read full news article

Aarey Drugs & Pharmaceuticals Ltd Hits Lower Circuit Amid Heavy Selling Pressure

2026-01-12 13:00:19

Shares of Aarey Drugs & Pharmaceuticals Ltd plunged to their lower circuit limit on 12 Jan 2026, reflecting intense selling pressure and panic among investors. The stock closed at ₹66.67, down 3.89% on the day, marking a significant underperformance relative to its sector and the broader market.

Read full news article

Aarey Drugs & Pharmaceuticals Ltd is Rated Strong Sell

2026-01-02 10:10:32

Aarey Drugs & Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 28 Nov 2025, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 02 January 2026, providing investors with the latest perspective on the company’s position.

Read full news article

Aarey Drugs & Pharmaceuticals Ltd Hits Lower Circuit Amid Heavy Selling Pressure

2025-12-29 14:00:11

Shares of Aarey Drugs & Pharmaceuticals Ltd plunged to their lower circuit limit on 29 Dec 2025, succumbing to intense selling pressure that saw the stock lose nearly 5% in a single session. The micro-cap pharmaceutical company’s stock closed at ₹67.65, down ₹3.12 or 4.41%, marking a continuation of a sharp downward trend amid weak investor sentiment and unfilled supply on the order books.

Read full news article

Aarey Drugs Sees Revision in Market Evaluation Amid Challenging Financials

2025-12-22 10:10:35

Aarey Drugs, a microcap player in the Pharmaceuticals & Biotechnology sector, has undergone a revision in its market evaluation reflecting recent shifts in its financial and technical outlook. This adjustment follows a detailed reassessment of the company’s quality, valuation, financial trends, and technical indicators, highlighting ongoing challenges and market dynamics affecting its performance.

Read full news article

View All News